CD103+/PD-1+T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition

被引：0
|
作者：
Bottai, G.
Loi, S.
Sotiriou, C.
Roncalli, M.
Pusztai, L.
Reis-Filho, J. S.
Santarpia, L.
机构：
[1] Humanitas Clin & Res Ctr, Milan, Italy
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Inst Jules Bordet, Brussels, Belgium
[4] Humanitas Univ, Milan, Italy
[5] Yale Canc Ctr, New Haven, CT USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-04-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-04-16
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Development of Triple-Negative Breast Cancer-Targeted Liposomes with MUC16 Binding Peptide Ligand in Triple-Negative Breast Cancer Cells
    Hagimori, Masayori
    Kato, Naoya
    Orimoto, Akira
    Suga, Tadaharu
    Kawakami, Shigeru
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (06) : 1740 - 1745
  • [32] Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
    Duncan, James S.
    Whittle, Martin C.
    Nakamura, Kazuhiro
    Abell, Amy N.
    Midland, Alicia A.
    Zawistowski, Jon S.
    Johnson, Nancy L.
    Granger, Deborah A.
    Jordan, Nicole Vincent
    Darr, David B.
    Usary, Jerry
    Kuan, Pei-Fen
    Smalley, David M.
    Major, Ben
    He, Xiaping
    Hoadley, Katherine A.
    Zhou, Bing
    Sharpless, Norman E.
    Perou, Charles M.
    Kim, William Y.
    Gomez, Shawn M.
    Chen, Xin
    Jin, Jian
    Frye, Stephen V.
    Earp, H. Shelton
    Graves, Lee M.
    Johnson, Gary L.
    CELL, 2012, 149 (02) : 307 - 321
  • [33] Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
    Granados-Principal, Sergio
    Liu, Yi
    Guevara, Maria L.
    Blanco, Elvin
    Choi, Dong Soon
    Qian, Wei
    Patel, Tejal
    Rodriguez, Angel A.
    Cusimano, Joseph
    Weiss, Heidi L.
    Zhao, Hong
    Landis, Melissa D.
    Dave, Bhuvanesh
    Gross, Steven S.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2015, 17
  • [34] Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
    Sergio Granados-Principal
    Yi Liu
    Maria L Guevara
    Elvin Blanco
    Dong Soon Choi
    Wei Qian
    Tejal Patel
    Angel A Rodriguez
    Joseph Cusimano
    Heidi L Weiss
    Hong Zhao
    Melissa D Landis
    Bhuvanesh Dave
    Steven S Gross
    Jenny C Chang
    Breast Cancer Research, 17
  • [35] Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells
    You, Kyu Sic
    Yi, Yong Weon
    Kwak, Sahng-June
    Seong, Yeon-Sun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) : 828 - 840
  • [36] Combined immunotherapy for metastatic triple-negative breast cancer based on PD-1/PD-L1 immune checkpoint blocking
    He, Rui
    Yuan, Xing
    Chen, Zeran
    Zheng, Yongfeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [37] Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer
    Bullock, Kennady K.
    Richmond, Ann
    CANCERS, 2024, 16 (12)
  • [38] Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer
    Li, Xuefei
    Gruosso, Tina
    Zuo, Dongmei
    Omeroglu, Atilla
    Meterissian, Sarkis
    Guiot, Marie-Christine
    Salazar, Adam
    Park, Morag
    Levine, Herbert
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (09) : 3678 - 3687
  • [39] PD-1 Inhibitor promising in treatment of triple-negative breast cancer
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) : 1298 - 1298
  • [40] Anti-PD-L1 for metastatic triple-negative breast cancer
    Gibson, Josefine
    LANCET ONCOLOGY, 2015, 16 (06): : E264 - E264
12345